2023-04-03 16:20:06 ET
- Legend Biotech ( NASDAQ: LEGN ) announced on Monday the appointments of Michel Vounatsos, former CEO of Biogen Inc., and John Maraganore, former CEO of Alnylam Pharma, as advisors for strategic initiatives to advance the company’s cell therapy platforms.
- The company is developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy.
- Press Release
For further details see:
Legend Biotech appoints former CEO of Biogen as advisor